Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M101,418Revenue $M16,383Net Margin (%)10.9Altman Z-Score6.1
Enterprise Value $M103,480EPS $1.1Operating Margin %17.0Piotroski F-Score7
P/E(ttm)56.9Beneish M-Score-2.1Pre-tax Margin (%)14.9Higher ROA y-yN
Price/Book6.710-y EBITDA Growth Rate %-1.4Quick Ratio1.6Cash flow > EarningsY
Price/Sales6.25-y EBITDA Growth Rate %-14.3Current Ratio1.8Lower Leverage y-yY
Price/Free Cash Flow64.7y-y EBITDA Growth Rate %-22.0ROA % (ttm)5.4Higher Current Ratio y-yN
Dividend Yield %2.4PEG--ROE % (ttm)11.8Less Shares Outstanding y-yY
Payout Ratio %138Shares Outstanding M1,668ROIC % (ttm)5.1Gross Margin Increase y-yY

Gurus Latest Trades with BMY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BMYVanguard Health Care Fund 2015-06-30 Add0.11%$63 - $69.15
($65.88)
$ 60.82-8%Add 1.90%43,718,751
BMYMario Gabelli 2015-06-30 Reduce-0.01%$63 - $69.15
($65.88)
$ 60.82-8%Reduce 3.66%678,636
BMYRonald Muhlenkamp 2015-06-30 Reduce-0.01%$63 - $69.15
($65.88)
$ 60.82-8%Reduce 0.26%211,620
BMYDodge & Cox 2015-06-30 Reduce$63 - $69.15
($65.88)
$ 60.82-8%Reduce 7.86%80,928
BMYKen Fisher 2015-06-30 Add$63 - $69.15
($65.88)
$ 60.82-8%Add 6.77%34,636
BMYKahn Brothers 2015-06-30 Add$63 - $69.15
($65.88)
$ 60.82-8%Add 1.41%28,800
BMYFirst Eagle Investment 2015-06-30 Reduce$63 - $69.15
($65.88)
$ 60.82-8%Reduce 8.05%13,325
BMYVanguard Health Care Fund 2015-03-31 Add0.53%$58.48 - $68.47
($62.6)
$ 60.82-3%Add 9.85%42,902,031
BMYBrian Rogers 2015-03-31 Reduce-0.09%$58.48 - $68.47
($62.6)
$ 60.82-3%Reduce 7.18%5,814,800
BMYMario Gabelli 2015-03-31 Reduce$58.48 - $68.47
($62.6)
$ 60.82-3%Reduce 0.75%704,425
BMYKen Fisher 2015-03-31 Add$58.48 - $68.47
($62.6)
$ 60.82-3%Add 5.54%32,441
BMYRonald Muhlenkamp 2015-03-31 Reduce$58.48 - $68.47
($62.6)
$ 60.82-3%Reduce 0.06%212,170
BMYDodge & Cox 2015-03-31 Reduce$58.48 - $68.47
($62.6)
$ 60.82-3%Reduce 3.52%87,828
BMYVanguard Health Care Fund 2014-12-31 Add0.08%$48.92 - $61.3
($56.49)
$ 60.828%Add 1.50%39,056,361
BMYKahn Brothers 2014-12-31 Add0.01%$48.92 - $61.3
($56.49)
$ 60.828%Add 2.71%28,400
BMYKen Fisher 2014-12-31 Reduce$48.92 - $61.3
($56.42)
$ 60.828%Reduce 39.96%30,739
BMYRonald Muhlenkamp 2014-12-31 Reduce$48.92 - $61.3
($56.49)
$ 60.828%Reduce 0.09%212,290
BMYRuane Cunniff 2014-12-31 Buy $48.92 - $61.3
($56.53)
$ 60.828%New holding3,670
BMYDodge & Cox 2014-12-31 Add$48.92 - $61.3
($56.49)
$ 60.828%Add 0.66%91,028
BMYMario Gabelli 2014-12-31 Add$48.92 - $61.3
($56.49)
$ 60.828%Add 1.35%709,715
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BMY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BMY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ANDREOTTI LAMBERTODirector 2015-08-03Sell315,000$65.36-6.95view
Caldarella Joseph CSVP & Controller 2015-06-04Sell16,972$65.71-7.44view
Schmukler Louis SPres., Global Mfg. & Supply 2015-03-16Sell12,000$66.96-9.17view
Cuss Francis MEVP & CSO 2015-03-16Sell114,666$67.81-10.31view
Moed Samuel JSVP, Strat Plan & Analysis 2015-03-13Sell591$66.67-8.77view
Moed Samuel JSVP, Strat Plan & Analysis 2015-03-10Sell10,343$65.84-7.62view
Elicker John ESVP Pub Affairs & Inv Relation 2015-03-06Sell10,468$66.24-8.18view
LEUNG SANDRAGeneral Counsel & Secretary 2015-02-17Sell11,746$60.390.71view
Moed Samuel JSVP, Strat Plan & Analysis 2015-02-12Sell3,880$59.262.63view
Moed Samuel JSVP, Strat Plan & Analysis 2015-02-06Sell21,478$60.151.11view

Quarterly/Annual Reports about BMY:

News about BMY:

Articles On GuruFocus.com
Weekly Insider Sells Highlight: IMS, NOW, BMY, EA Aug 11 2015 
Will Bill Ackman Go After Express Scripts Next? Jun 30 2015 
Bristol-Myers Squibb Takes A Step Up On Cancer Drugs, But The Cost Tells A Different Story Jun 22 2015 
gild Jun 02 2015 
Abbvie Inc. Dividend Stock Analysis May 26 2015 
Baxter Takes The Acquisition Route To Grow In The Oncology Segment May 14 2015 
Bayer Enters Into Collaboration With Isis For Enhancing Its Drug Portfolio May 07 2015 
Vanguard Adds to Four of Its Largest Stakes May 04 2015 
HealthCare Stocks That Can Make Investors Healthier Apr 08 2015 
Bristol-Myers Signs An Exclusive Pact In Gene Therapy For Treating Cardiovascular Disorders Apr 08 2015 

More From Other Websites
Bristol-Myers Squibb's success in Tampa was a major draw for Johnson & Johnson Aug 27 2015
Allied-Bristol Life Sciences Licenses Platform Technology and Lead Molecules from Yale University Aug 27 2015
2Q15 Performance of AstraZeneca’s ING Segment Aug 26 2015
Short Sellers Have Mixed Feelings on Major Pharma Aug 26 2015
Bristol-Myers Squibb (BMY) Stock Gets Rating Upgrade at Piper Jaffray Aug 24 2015
Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis (apixaban) at the ESC Congress 2015 Aug 24 2015
Piper Jaffray Upgrades Bristol-Myers Squibb, Sees Valuation As Fair Aug 24 2015
Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis (apixaban) at the ESC Congress 2015 Aug 24 2015
Analysts' Actions -- Abercrombie & Fitch, Bristol-Myers, Nike, Fox and More Aug 24 2015
Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis (apixaban) at the ESC Congress 2015 Aug 24 2015
Bristol-Myers upgraded by Piper Jaffray Aug 24 2015
Broken companies vs. broken stocks Aug 21 2015
Bristol-Myers Strong Reliance On New Drugs Growth: Is It A Huge Risk? Aug 20 2015
Cramer: Fed who? Stocks you need to be buying now Aug 19 2015
3 Ways to play biotech breakthroughs Aug 18 2015
Wait, There are Still Cheap Pharma Stocks? Aug 18 2015
4 Top Pharma Stocks That Should Outperform Out To 2016 Aug 18 2015
U.S. Food and Drug Administration Extends Action Date for Supplemental Biologics License Application... Aug 17 2015
R-PHARM Acquires IXEMPRA(R) (ixabepilone) From Bristol-Myers Squibb and Launches U.S. Commercial... Aug 17 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK